A61P 11 - Drugs for disorders of the respiratory system

Patents for A61P 11 - Drugs for disorders of the respiratory system (87,767)
12/2001
12/06/2001	WO2001092526A1 Human kcnq5 potassium channel, methods and compositions thereof
12/06/2001	WO2001092491A2 Mammalian protein phosphatases identified by in-silico analysis
12/06/2001	WO2001092490A2 Isolated human aminotransferase proteins, nucleic acid molecules encoding human aminotransferase proteins, and uses thereof
12/06/2001	WO2001092485A1 DNAs ENCODING MAMMALIAN HISTAMINE RECEPTOR OF THE H4 SUBTYPE
12/06/2001	WO2001092304A2 Transporters and ion channels
12/06/2001	WO2001092267A2 Dihydropyridine compounds for the inhibition of calcium-influx
12/06/2001	WO2001092262A1 New crystalline and amorphous form of a triazolo(4,5-d)pyrimidine compound
12/06/2001	WO2001092256A1 2,7-naphthyridine derivatives
12/06/2001	WO2001092253A2 Inhibitors of alpha l beta 2 mediated cell adhesion
12/06/2001	WO2001092227A1 Chemical compounds
12/06/2001	WO2001092202A1 Il-8 receptor antagonists
12/06/2001	WO2001091800A1 Ubiquitin promoter in vectors for gene therapy in respiratory tract
12/06/2001	WO2001091732A2 Medicament for combating respiratory depression
12/06/2001	WO2001091729A1 Formulation based on heparin, glycosaminoglycan or heparinoid, use of the formulation and the formulation base
12/06/2001	WO2001091719A1 Nasal ointment based on white petroleum jelly
12/06/2001	WO2001060837A3 Polypeptoid pulmonary surfactants
12/06/2001	WO2001046392A3 Homologues of human heparanase and splice variants thereof
12/06/2001	WO2001044167A8 Quaternary ammonium compounds and their use as anti-tussive agents
12/06/2001	WO2001032127A3 Method and compositions for treating pulmonary diseases
12/06/2001	WO2001017999A3 Amino-triazolopyridine derivatives
12/06/2001	WO2001012775A8 25 human secreted proteins
12/06/2001	WO2001010848A3 Diazocin-dione derivatives and their use s tryptase inhibitors
12/06/2001	WO2000077018A3 Purine derivatives
12/06/2001	WO2000061750A3 TYROSINE KINASE SUBSTRATE (Tks) PROTEINS
12/06/2001	US20010049396 Symptomatic relief
12/06/2001	US20010049391 Tramadol or a pharmaceutically acceptable derivative or salt thereof and a carrier
12/06/2001	US20010049371 Reducing levels of tumor necrosis factor alpha; inhibition of undesireable levels of matrix metalloproteinases
12/06/2001	US20010049106 ADAM (A Disintegrin And Metalloprotease) family of metalloproteases, and in addition contain thrombospondin domain (TS); treating diabetes, arthritis, cancer, solid tumors, autoimmune diseases
12/06/2001	DE10026699A1 Formulierung auf Heparin-, Glycosaminoglycan- oder Heparinoidbasis und Verwendung der Formulierung sowie der Formulierungsgrundlage Formulation of heparin, glycosaminoglycan or Heparinoidbasis and use of the formulation and the formulation base
12/06/2001	CA2413188A1 Petrolatum-based nose ointment
12/06/2001	CA2411323A1 Il-8 receptor antagonists
12/06/2001	CA2410734A1 Dnas encoding mammalian histamine receptor of the h4 subtype
12/06/2001	CA2410655A1 Dihydropyridine compounds for the inhibition of calcium-influx
12/06/2001	CA2410650A1 Medicament for combating respiratory depression
12/06/2001	CA2410489A1 Human kcnq5 potassium channel, methods and compositions thereof
12/06/2001	CA2410087A1 Mammalian protein phosphatases identified by in-silico analysis
12/06/2001	CA2410084A1 Transporters and ion channels
12/06/2001	CA2410033A1 Isolated human aminotransferase proteins, nucleic acid molecules encoding human aminotransferase proteins, and uses thereof
12/06/2001	CA2409617A1 2,7-naphthyridine derivatives
12/06/2001	CA2409311A1 Regulators of apoptosis
12/05/2001	EP1160255A1 Monovalent antibody fragments
12/05/2001	EP1160254A1 Human vanilloid receptor-like proteins
12/05/2001	EP1160248A1 N-(Isoxazol-5-yl)-sulfonamide derivatives and their use as endothelin antagonists
12/05/2001	EP1160247A1 6,5-Fused aromatic ring systems having enhanced phosphodiesterae IV inhibitory activity
12/05/2001	EP1159975A2 Anti-angiogenic compositions and methods of use
12/05/2001	EP1159974A1 Anti-angiogenic compositions and methods of use
12/05/2001	EP1159958A1 Vaseline-based nasal ointment
12/05/2001	EP1159408A2 Hermansky pudlak syndrome protein-interacting proteins and methods of use thereof
12/05/2001	EP1159300A2 Humanized immunoglobulin reactive with b7 molecules and methods of treatment therewith
12/05/2001	EP1159284A1 33 human secreted proteins
12/05/2001	EP1159275A2 Imidazole compounds as histamine h3 ligands
12/05/2001	EP1159264A2 INHIBITORS OF FACTOR Xa
12/05/2001	EP1158996A1 Novel amide derivatives as growth hormone secretagogues
12/05/2001	EP1158988A2 Corticosteroid formulation
12/05/2001	EP1158970A1 Combinations of formoterol and a tiotropium salt
12/05/2001	EP1158958A1 Improved powdery pharmaceutical compositions for inhalation
12/05/2001	EP0769056B1 NON-SPLICING VARIANTS OF gp350/220
12/05/2001	EP0605493B1 THIADIAZOLO (4,3-a)PYRIDINE DERIVATIVES, METHODS OF PREPARING THEM AND DRUGS CONTAINING THEM
12/05/2001	EP0445255B2 USE OF HYALURONIC ACID IN COMBINATION WITH ASCORBIC ACID, ANTITUMOUR AGENTS AND/OR NSAIDs FOR TREATING CANCER
12/05/2001	CN1325441A Modified exosomes and uses
12/05/2001	CN1325407A Platelet-derived growth factor D, DNA coding therefor and uses thereof
12/05/2001	CN1325390A 2-ureido-thiazole derivatives, process for their preparation, and their use as antitumor agents
12/05/2001	CN1325389A 2-amino-thiazole derivatives, process for their preparation, and their use as antitumor agents
12/05/2001	CN1325299A Orally administered controlled drug delivery system providing temporal and spatial control
12/05/2001	CN1324646A Compound pharynx-benefiting tea and its prepn.
12/05/2001	CN1324640A External-use medicine for treating cough and diarrhoea in the four seasons
12/05/2001	CN1075816C Methods for in vivo reduction of nitric oxide levels and compositions sueful therefor
12/05/2001	CN1075812C Prodrugs of morpholine tachykinin receptor antagonists
12/05/2001	CN1075731C Medicine for treating nasal polyp
12/04/2001	US6326492 Heterocyclic protease inhibitors
12/04/2001	US6326401 Formulation for the oromucosal, in particular pernasal, route
12/04/2001	US6326388 Substituted 1,3,4-oxadiazoles and a method of reducing TNF-alpha level
12/04/2001	US6326359 Adenosine A2A receptor agonists as antiinflammatory agents
12/01/2001	CA2347276A1 I g e-dependent histamine-releasing factor (hrf) receptor, hrf-binding peptides and nucleic acids encoding the same, and uses thereof
11/2001
11/30/2001	CA2348847A1 New isoxazole-sulfonamide endothelin antagonists
11/29/2001	WO2001090421A2 Method of detecting inflammatory lung disorders
11/29/2001	WO2001090363A1 Chimeric arterivirus-like particles
11/29/2001	WO2001090359A2 G-protein coupled receptors
11/29/2001	WO2001090334A2 Drug metabolizing enzymes
11/29/2001	WO2001090186A1 Methods for identifying modulators of the interaction between lap (latency associated peptide) and intergrin alpha.v.beta.3 and medical use thereof
11/29/2001	WO2001090129A2 Prophylactic and therapeutic treatment of infectious, autoimmune and allergic diseases with mono and disaccharide-base compounds
11/29/2001	WO2001090110A1 Macrolides
11/29/2001	WO2001090106A2 Tryasolyl tropane derivatives as ccr5 modulators
11/29/2001	WO2001090104A2 -(pyrrolidin-1-ylmethyl)-3-(pyrrol-2-ylmethylidene)-2-indolinone derivatives and their use as modulators of protein kinases
11/29/2001	WO2001090103A2 3-(pyrrol-2-ylmethylidene)-2-indolinone derivatives and their use as protein kinase modulators
11/29/2001	WO2001090101A1 Arylmethylamine derivatives for use as tryptase inhibitors
11/29/2001	WO2001090100A1 Bicyclyl or heterobicyclylmethanesulfonylamino-substituted n-hydroxyformamides
11/29/2001	WO2001090086A1 A polymorph of 5-(4-aminosulfonyl-3-fluorophenyl)-4-cyclohexyl-2-methyloxazole
11/29/2001	WO2001090083A1 1,4-diazepan-2,5-dione derivatives and their use as nk-1 receptor antagonists
11/29/2001	WO2001090082A1 Substituted 1-aminoalkyl-lactams and their use as muscarinic receptor antagonists
11/29/2001	WO2001090081A1 Substituted 1-aminoalkyl-lactams and their use as muscarinic receptor antagonists
11/29/2001	WO2001090076A1 Fluoroalkoxy-substituted benzamide dichloropyridinyl n-oxide pde4 inhibitor
11/29/2001	WO2001090074A2 BENZOPHENONES AS INHIBITORS OF IL-1β AND TNF-$g(a)
11/29/2001	WO2001090070A2 Caspase inhibitors and uses thereof
11/29/2001	WO2001090068A2 Mannich base prodrugs of 3-(pyrrol-2-ylmethylidene)-2-indolinone derivatives and their use a modulators of protein kinases
11/29/2001	WO2001090063A2 Prodrug of an ice inhibitor
11/29/2001	WO2001090060A1 Disulfide derivatives useful for treating allergic diseases
11/29/2001	WO2001090059A1 Aniline disulfide derivatives for treating allergic diseases
11/29/2001	WO2001089616A1 Aerosol container for formulations of salmeterol xinafoate
11/29/2001	WO2001089589A1 A novel treatment for cough

1 ... 690 691 692 693 694 695 696 697 698 699 700 701 702 703 704 705 706 707 708 709 710 ... 878